Professor Sulev Kõks obtained his MD (1995) and PhD (1999) degrees at the University of Tartu, Estonia.
Professor Kõks’ PhD investigated the role of cholecystokinin (CCK) in the regulation of emotional behaviour, with a main emphasis on anxiety and pain regulation. In 2006, Professor Kõks completed his postdoctoral research in genomics at King’s College, London. Professor Kõks has also been involved in studies on the genetics of mood disorders, translational research, genetics of rare diseases and genetic mechanisms of common diseases. In 2003, he was awarded the European College of Neuropsychopharmacology (ECNP) Fellowship Award and continued his research as a Senior Research Fellow at the University of Tartu.
Later in his career, Professor Kõks trained in genomics, clinical research, research design and analysis. Professor Kõks is currently the leader of the Genetic Epidemiology Research group and involved in the implementation of genomics in clinical research. His main research goal is to use genomic technologies in longitudinal studies as predictors for disease outcomes such as Parkinson’s disease, psoriasis, psoriatic arthritis, osteoporosis and osteosarcoma.